UPDATE : Monday, September 7, 2020
상단여백
HOME Pharma
Intra-articular injection Conjuran recognized as new medical tech
  • By Lee Hye-seon
  • Published 2019.01.15 14:07
  • Updated 2019.01.15 14:07
  • comments 0

The government recognized Pharma Research Products’ intra-articular injection Conjuran as a new medical technology.

The Ministry of Health and Welfare said Tuesday it has included the product in the list of new medical technologies, notifying the safety and efficacy of “intra-articular injection using polynucleotide sodium.”

The product can help relieve pain and improve joint function by reducing the mechanical friction of the joint area in patients with knee osteoarthritis, it said.

Polynucleotide sodium, the ingredient of Conjuran, is a safe DNA material that exists in human. The company extracts it from reproductive cells of salmon and refines it with high purification process to make it suitable for injection into a human body such as joints.

“Conjuran will be a new therapeutic alternative for patients with arthritis. We expect to achieve fast sale growth thanks to the product’s monopolistic status, without any competition against later runners,” an official at Pharma Research Products said. “Hospitals and clinics can use our new medical technology as non-reimbursed service. We plan to submit reimbursement application to the Health Insurance Review and Assessment Service.”

lhs@docdocdoc.co.kr

<© Korea Biomedical Review, All rights reserved.>

Other articles by Lee Hye-seon
iconMost viewed
Comments 0
More
Please leave the first comment.
여백
여백
여백
Back to Top